Otitis Media

Pediatrics in Review

Volumn 31, Issue 3, 2010, Pages 102-116

  Gould, Jane M ^a,b   Matz, Paul S ^c  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b ST CHRISTOPHER'S HOSPITAL FOR CHILDREN   (United States)

^c Advocare Haddon Pediatric Group   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; ANTIBIOTIC AGENT; AZITHROMYCIN; BENZOCAINE; CEFDINIR; CEFPODOXIME; CEFTRIAXONE; CEFUROXIME; CIPROFLOXACIN; CLARITHROMYCIN; CLINDAMYCIN; IBUPROFEN; PARACETAMOL; PNEUMOCOCCUS VACCINE;

ACUTE OTITIS MEDIA; ADENOVIRUS; ALLERGIC RHINITIS; ANAPHYLAXIS; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; AUDITORY TUBE; AUDITORY TUBE DYSFUNCTION; BIOFILM; BOTTLE FEEDING; CHLAMYDIA; CHOLESTEATOMA; CHRONIC SUPPURATIVE OTITIS MEDIA; CLEFT PALATE; CORONAVIRUS; CRANIOFACIAL MALFORMATION; DISEASE ASSOCIATION; DRUG MEGADOSE; EARDRUM; ENTEROBACTER; ENTEROVIRUS; ESCHERICHIA COLI; FEVER; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION; GROWTH RATE; HAEMOPHILUS INFLUENZAE; HEARING LOSS; HOST RESISTANCE; HUMAN; HUMAN METAPNEUMOVIRUS; IMMUNE RESPONSE; INCIDENCE; INFLUENZA VIRUS A; INFLUENZA VIRUS B; KLEBSIELLA PNEUMONIAE; LARYNX SPASM; LEUKOCYTE FUNCTION; MASTICATION; MASTOIDITIS; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MIDDLE EAR; MIDDLE EAR EFFUSION; MIDDLE EAR PRESSURE; MORAXELLA CATARRHALIS; MYCOPLASMA; MYRINGOTOMY; NASOPHARYNGEAL ASPIRATION; NASOPHARYNX; OTALGIA; OTITIS MEDIA; OTOSCOPY; OTOTOXICITY; PACIFIER; PENICILLIN ALLERGY; PHENOTYPE; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PREDICTOR VARIABLE; PROTEUS; PSEUDOMONAS AERUGINOSA; RECURRENT DISEASE; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; REVIEW; RHINOVIRUS; RISK FACTOR; RNA VIRUS INFECTION; SEASONAL VARIATION; SECRETORY OTITIS MEDIA; STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS GROUP A; STREPTOCOCCUS PNEUMONIA; TREATMENT INDICATION; TYMPANOMETRY; TYMPANOSTOMY TUBE; UPPER RESPIRATORY TRACT INFECTION; URTICARIA; VIRUS ISOLATION; WATCHFUL WAITING; WHEEZING; YAWNING;

ACUTE DISEASE; ANTI-BACTERIAL AGENTS; CHILD; HUMANS; OTITIS MEDIA; OTITIS MEDIA WITH EFFUSION; RISK FACTORS;

EID: 77749292427     PISSN: 01919601     EISSN: 15263347     Source Type: Journal    
DOI: 10.1542/pir.31-3-102     Document Type: Review

References (31)

1. Bluestone CD, Klein JO. Otitis Media in Infants and Children. 4th ed. Hamilton, Ontario, Canada: BC Decker, Inc; 2007
2. American Academy of Pediatrics. Subcommittee on Management of Acute Otitis Media. Diagnosis and management of acute otitis media. Pediatrics. 2004;113:1451-1465
3. Chonmaitree T, Revai K, Grady JJ, et al. Viral upper respiratory tract infection and otitis media complication in young children. Clin Infect Dis. 2008;46:815-823
4. Le Bideau M, Mouzard A, Chamoux C, et al. Bacteriological study in acute otitis media. Arch Pediatr. 1997;4:213-218
5. Sade J, Russo E, Fuchs C, et al. Is secretory otitis media a single disease entity? Ann Otol Rhinol Laryngol. 2003;112:342-347
6. Ruohola A, Meurman O, Nikkari S, et al. Microbiology of acute otitis media in children with tympanostomy tubes: prevalences of bacteria and viruses. Clin Infect Dis. 2006;43:1417-1422
7. Leibovitz E, Asher E, Piglansky L, et al. Is bilateral otitis media clinically different than unilateral acute otitis media? Pediatr Infect Dis J. 2007;26:589-592
8. Hong W, Pang B, West-Barnette S. Phosphorylcholine expression by nontypeable Haemophilus influenzae correlates with maturation of biofilm communities in vitro and in vivo. J Bacteriol. 2007;189:8300-8307
9. Berkun Y, Nir-Paz R, Ben Ami A. Acute otitis media in the first two months of life: characteristics and diagnostic difficulties. Arch Dis Child. 2008;93:690-694
10. American Academy of Pediatrics Subcommittee on Otitis Media with Effusion; American Academy of Family Physicians; American Academy of Otolaryngology-Head and Neck Surgery. Otitis media with effusion. Pediatrics. 2004;113:1412-1429
11. Eskola J, Kilpi T, Palmu A, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403-409
12. Fireman B, Black S, Shinefield HR, et al. Impact of pneumococcal conjugate vaccine on otitis media. Pediatr Infect Dis J. 2003;22:10-16
13. Poehling KA, Lafleur BJ, Szilagyi PG, et al. Population-based impact of pneumococcal conjugate vaccine in young children. Pediatrics. 2004;114:755-761
14. Grijalva CG, Poehling KA, Nuorti JP, et al. National impact of universal childhood immunization with pneumococcal conjugate vaccine on outpatient medical care visits in the United States. Pediatrics. 2006;118:865-873
15. Casey JR, Pichichero ME. Changes in frequency and pathogens causing acute otitis media in 1995-2003. Pediatr Infect Dis J. 2004;23:824-828
16. Block SL, Hedrick J, Harrison CJ, et al. Community-wide vaccination with the heptavalent pneumococcal conjugate vaccine significantly alters the microbiology of acute otitis media. Pediatr Infect Dis J. 2004;23:829-833
17. Pichichero ME, Casey JR, Hoberman A, et al. Pathogens causing recurrent and difficult-to-treat acute otitis media, 2003-2006. Clin Pediatr. 2008;47:901-906
18. Pichichero ME, Casey JR. Emergence of a multiresistant serotype 19A pneumococcal strain not included in the 7-valent conjugate vaccine as an otopathogen in children. JAMA. 2007;298:1772-1778
19. Ongkasuwan J, Valdez TA, Hulten KG, et al. Pneumococcal mastoiditis in children and the emergence of multidrug-resistant serotype 19A isolates. Pediatrics. 2008;22:34-39
20. Rosenfeld RM, Kay D. Natural history of untreated otitis media. In: Rosenfeld RM, Bluestone CD, eds. Evidence-based Otitis Media. 2nd ed. Hamilton, Ontario, Canada: BC Decker Inc; 2003:180-198
21. Rosenfeld RM, Vertrees JE, Carr J, et al. Clinical efficacy of antimicrobial drugs for acute otitis media: metaanalysis of 5400 children from thirty-three randomized trials. J Pediatr. 1994;124:355-367
22. Del Mar C, Glasziou P, Hayem M. Are antibiotics indicated as initial treatment for children with acute otitis media? A metaanalysis. BMJ. 1997;314:1526-1529
23. Glasziou PP, Del Mar CB, Hayem M, Sanders SL. Antibiotics for acute otitis media in children. Cochrane Database Syst Rev. 2000;4:CD000219
24. Marcy M, Takata G, Chan LS, et al. Management of acute otitis media. Evidence Report/Technology Assessment No. 15. AHRQ Publication No. 01-E010. Rockville, Md: Agency for Healthcare Research and Quality; 2001
25. Ruohola A, Meurman O, Nikkari S. The dynamics of bacteria in the middle ear during the course of acute otitis media with tympanostomy tube otorrhea. Pediatr Infect Dis J. 2007;26:892-896
26. Macfadyen CA, Acuin JM, Gamble C. Systemic antibiotics versus topical treatments for chronically discharging ears with underlying eardrum perforations. Cochrane Database Syst Rev. 2006; 1:CD005608
27. Macfadyen CA, Acuin JM, Gamble C. Topical antibiotics without steroids for chronically discharging ears with underlying eardrum perforations. Cochrane Database Syst Rev. 2005;4:CD004618
28. Leach A, Wood Y, Gadil E. Topical ciprofloxacin versus topical framycetingramicidin-dexamethasone in Australian aboriginal children with recently treated chronic suppurative otitis media, a randomized controlled trial. Pediatr Infect Dis J. 2008;27:692-698
29. Paradise JL, Feldman HM, Campbell TF, et al. Tympanostomy tubes and developmental outcomes at 9 to 11 years of age. N Engl J Med. 2007;356:248-261
30. Shohet JA, de Jong AL. The management of pediatric cholesteatoma. Otolaryngol Clin N Am. 2002;35:841-851
31. Nguyen CV, Parikh SR, Adam HM. In brief: cholesteatoma. Pediatr Rev. 2008;29:330-331